Western University

Scholarship@Western
Medical Biophysics Publications

Medical Biophysics Department

7-20-2018

Oscillometry and pulmonary MRI measurements of ventilation
heterogeneity in obstructive lung disease: Relationship to quality
of life and disease control
Heather M Young
Fumin Guo
Rachel L Eddy
Geoffrey Maksym
Grace Parraga

Follow this and additional works at: https://ir.lib.uwo.ca/biophysicspub
Part of the Medical Biophysics Commons

Citation of this paper:
Young, Heather M; Guo, Fumin; Eddy, Rachel L; Maksym, Geoffrey; and Parraga, Grace, "Oscillometry and
pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: Relationship to
quality of life and disease control" (2018). Medical Biophysics Publications. 112.
https://ir.lib.uwo.ca/biophysicspub/112

J Appl Physiol 125: 73–85, 2018.
First published March 15, 2018; doi:10.1152/japplphysiol.01031.2017.

RESEARCH ARTICLE

Oscillometry and pulmonary MRI measurements of ventilation heterogeneity
in obstructive lung disease: relationship to quality of life and disease control
Heather M. Young,1,2 Fumin Guo,1,3 Rachel L. Eddy,1,2 Geoffrey Maksym,4 and Grace Parraga1,2,3
1

Robarts Research Institute, Western University, London, Ontario, Canada; 2Department of Medical Biophysics, Western
University, London, Ontario, Canada; 3Graduate Program in Biomedical Engineering, Western University, London, Ontario,
Canada; and 4School of Biomedical Engineering, Dalhousie University, Halifax, Nova Scotia, Canada
Submitted 19 November 2017; accepted in final form 7 March 2018

Young HM, Guo F, Eddy RL, Maksym G, Parraga G. Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and
disease control. J Appl Physiol 125: 73– 85, 2018. First published
March 15, 2018; doi:10.1152/japplphysiol.01031.2017.—Ventilation
heterogeneity is a hallmark finding in obstructive lung disease and
may be evaluated using a variety of methods, including multiplebreath gas washout and pulmonary imaging. Such methods provide an
opportunity to better understand the relationships between structural
and functional abnormalities in the lungs, and their relationships with
important clinical outcomes. We measured ventilation heterogeneity
and respiratory impedance in 100 subjects [50 patients with asthma,
22 ex-smokers, and 28 patients with chronic obstructive pulmonary
disease (COPD)] using oscillometry and hyperpolarized 3He magnetic
resonance imaging (MRI) and determined their relationships with
quality of life scores and disease control/exacerbations. We also
coregistered MRI ventilation maps to a computational airway tree
model to generate patient-specific respiratory impedance predictions
for comparison with experimental measurements. In COPD and
asthma patients, respectively, forced oscillation technique (FOT)derived peripheral resistance (5–19 Hz) and MRI ventilation defect
percentage (VDP) were significantly related to quality of life (FOT:
COPD  ⫽ 0.4, P ⫽ 0.004; asthma  ⫽ ⫺0.3, P ⫽ 0.04; VDP: COPD
 ⫽ 0.6, P ⫽ 0.003; asthma  ⫽ ⫺0.3, P ⫽ 0.04). Patients with
poorly controlled asthma (Asthmatic Control Questionnaire ⬎2) had
significantly increased resistance (5 Hz: P ⫽ 0.01; 5–19 Hz: P ⫽
0.006) and reactance (5 Hz: P ⫽ 0.03). FOT-derived peripheral
resistance (5–19 Hz) was significantly related to VDP in patients with
asthma and COPD patients (asthma:  ⫽ 0.5, P ⬍ 0.001; COPD:
 ⫽ 0.5, P ⫽ 0.01), whereas total respiratory impedance was related
to VDP only in patients with asthma (resistance 5 Hz:  ⫽ 0.3, P ⫽
0.02; reactance 5 Hz:  ⫽ ⫺0.5, P ⬍ 0.001). Model-predicted and
FOT-measured reactance (5 Hz) were correlated in patients with
asthma ( ⫽ 0.5, P ⫽ 0.001), whereas in COPD patients, modelpredicted and FOT-measured resistance (5–19 Hz) were correlated
( ⫽ 0.5, P ⫽ 0.004). In summary, in patients with asthma and COPD
patients, we observed significant, independent relationships for FOTmeasured impedance and MRI ventilation heterogeneity measurements with one another and with quality of life scores.
NEW & NOTEWORTHY In 100 patients, including patients with
asthma and ex-smokers, 3He MRI ventilation heterogeneity and respiratory system impedance were correlated and both were independently related to quality of life scores and asthma control. These
findings demonstrated the critical relationships between respiratory
system impedance and ventilation heterogeneity and their role in
Address for reprint requests and other correspondence: G. Parraga, Robarts
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determining quality of life and disease control. These observations
underscore the dominant role that abnormalities in the lung periphery
play in ventilation heterogeneity that results in patients’ symptoms.
asthma; COPD; forced oscillation technique; hyperpolarized 3He
MRI; respiratory system impedance

INTRODUCTION

Ventilation heterogeneity is a hallmark consequence of obstructive lung diseases such as asthma (26, 30, 56, 83) and
chronic obstructive pulmonary disease (COPD) (13, 82) and is
related to disease symptoms and control (13, 14, 30, 76).
Ventilation heterogeneity can be measured using a variety of
techniques, including multiple-breath gas washout methods
(10, 63, 64) and pulmonary imaging (3, 31, 68, 79, 81). Despite
decades of research that focused on the quantification and
development of our understanding of causes and clinical implications of ventilation abnormalities, many patients with
obstructive lung disease and ventilation heterogeneity still have
poor disease control and quality of life (4, 17, 60, 74). This
may be due in part to the fact that the complex structural and
biomechanical changes underlying ventilation heterogeneity
are still not fully understood (2, 23, 66), including those
contributed by airway abnormalities such as heterogeneous
airway diameter and tone (15, 55).
The forced oscillation technique (FOT), first developed over
50 yr ago (28), noninvasively probes the mechanical properties
of the respiratory system (respiratory system impedance) during quiet breathing by applying multifrequency pressure oscillations at the mouth. The measured impedance reflects both
resistance and reactance and is acquired at multiple frequencies
to ascertain the frequency dependence of resistance, which is
believed to be related to changes in the lung periphery (73).
This is extremely important, as the mechanical properties of
the lung periphery are known to be important determinants of
lung function (9). FOT has been used extensively to study
patients with COPD (25, 80, 86) and asthma (19, 24, 29, 80,
86), including the measurement of responses to bronchoconstriction in asthma (29) and to bronchodilation (24, 80, 86).
Previous studies have shown that both resistance and reactance
are sensitive to heterogeneous airway narrowing in asthma (41,
54), but the exact location of this airway narrowing could not
be identified. On the other hand, hyperpolarized 3He MRI
ventilation imaging has been used to identify the spatial location of ventilation abnormalities (which may reflect ventilation
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heterogeneity) in patients with asthma (3, 21, 22, 65, 66) and
patients with COPD (44, 50, 57, 62). MRI ventilation defects
reflect the severity of airflow obstruction (22, 49) and respond
to provocation in asthma (20, 65, 79) and treatment (3, 46, 48,
67). In addition, MRI-derived ventilation heterogeneity was
recently shown to be independently predictive of asthma control (68) and COPD exacerbations (47) and is related to
respiratory resistance and airway hyperresponsiveness in
asthma (53).
Computational airway modeling has also been used to study
the relationship between airway caliber and ventilation heterogeneity. Using an anatomical computational airway tree
model (69), the caliber of the airway lumen can be manipulated
to study the effects on respiratory impedance or ventilation
distribution. Previous studies suggest that airway narrowing
must occur heterogeneously throughout the entire airway tree
to replicate experimentally measured impedance in asthma (16,
71, 73). Airway narrowing near ventilation defects alone is not
sufficient (71, 73), and neither is narrowing large airways alone
(16). Another modeling study showed that ventilation abnormalities were positively correlated with increased resistance
(51). Numerous studies have probed structure-function relationships in asthma using biomechanical models informed by
3
He MRI (16, 52), PET (71, 73), and single photon emission
computed tomography (SPECT) (31), and some studies have
incorporated measured respiratory impedance in model calculations (16, 71, 72). However, only a single study in a small
group of patients with asthma has generated both model predictions of impedance and experimental measurements of impedance in the same patients for direct comparison (31).
There is a clear need for multiscale studies that combine
functional lung imaging, computational airway models, and
experimental oscillometry measurements to provide a deeper
understanding of the relationships between structure and function in obstructive lung disease. Ultimately, this should lead to
an understanding of how disease control and quality of life can
be improved in patients (8, 11, 42, 75). Therefore, the primary
objective of this work was to evaluate the relationships between patient outcomes such as disease control/exacerbations
and quality of life and hyperpolarized 3He MRI ventilation
defects and FOT-measured respiratory impedance. Our secondary objective was to incorporate ventilation MRI data in a
computational airway tree model to generate patient-specific
predictions of respiratory impedance and to compare these
predictions to FOT-measurements to better understand the
relationships between ventilation defects and biomechanical
changes in the lung periphery.
We hypothesize that quantitative measurements derived
from FOT and MRI, reflecting respiratory impedance and
peripheral heterogeneity, are predictive of disease control/
exacerbations and quality of life in ex-smokers, COPD patients, and patients with asthma. This would support the understanding that heterogeneity, especially in the lung periphery, is a determinant of reduced lung function.
METHODS

Study design. All participants provided written informed consent to
study protocols (NCT# NCT02351141, NCT02263794, NCT02279329) approved by the local research ethics board. Participants
between ages 18 to 70 yr with a current diagnosis of asthma and
patients between ages 50 to 90 yr with a history of smoking were

recruited from a tertiary care center and evaluated using spirometry,
plethysmography, FOT, and pulmonary MRI in a single visit. Exsmokers with COPD were identified using the Global initiative for
chronic Obstructive Lung Disease (GOLD) criteria (84). Disease
control was evaluated in patients with asthma using the Asthma
Control Questionnaire [ACQ (40) with permission], and ex-smokers’
exacerbation events requiring hospitalization were used as a surrogate
measure of disease control. The number of exacerbations requiring
hospitalization was determined using patient hospital records during
the 2.5-yr period following the visit to the research center. Patient
quality of life was evaluated using the Asthma Quality of Life
Questionnaire [AQLQ (39) with permission] for asthma and the St.
George’s Respiratory Questionnaire [SGRQ (38) with permission] for
ex-smokers. For participants with asthma, all imaging and pulmonary
function tests were acquired at baseline and within 1.5 h after
administration of four 100-g doses of Novo-Salbutamol HFA (Teva
Novopharm, Toronto, ON, Canada) using a metered dose inhaler with
an AeroChamber Plus spacer (Trudell Medical International, London,
ON, Canada). In this work, baseline measurements were investigated.
For ex-smokers, all data were acquired within 1.5 h after administration of four 100-g doses of salbutamol as described for patients with
asthma. Spirometry and body plethysmography were performed according to the American Thoracic Society guidelines (58) using a
whole-body system (MedGraphics Corporation, Saint Paul, MN).
FOT measurements were acquired at multiple frequencies from 5 to
37 Hz using the TremoFlo C-100 Airwave Oscillometry System
(Thorasys, Montreal, QC, Canada). For this study, only measurements
at 5 and 19 Hz were included, as they have been previously identified
to reflect impedance throughout the respiratory system and changes in
the lung periphery.
Image acquisition and analysis. MRI was performed on a wholebody 3T system (MR750 Discovery, GEHC, Milwaukee, WI) with
broadband imaging capability. 3He MRI was acquired using a singlechannel, rigid elliptical transmit/receive chest coil (RAPID Biomedical GmbH, Wuerzburg, Germany). The 3He gas was polarized to
30%– 40% polarization using a spin-exchange optical polarizer (Polarean Inc., Durham, NC). Subjects were positioned supine in the
scanner with their arms raised above their head and inhaled a 1-liter
gas mixture of 3He/N2 (25% 3He by volume) from functional residual
capacity. Image acquisition was performed under breath-hold conditions (62). The hyperpolarized 3He magnetic resonance (MR) images
were analyzed using custom software as previously described (34).
Briefly, a single user (H.M.Y.) placed seeds on the 1H and 3He MR
images to label the lung and the surrounding tissue, and image
segmentation was completed using a convex optimization technique.
3
He ventilation defects were identified using a k-means clustering
approach (45), and ventilation defect percentage (VDP) was calculated as the total ventilation defect volume normalized to the thoracic
cavity volume. The ventilation cluster map for each subject was then
nonrigidly registered to the computational airway tree as previously
described (52).
Computational modeling. We adapted a three-dimensional (3-D)
airway tree consisting of 64,895 airways (M. Tawhai, Univeristy of
Auckland) to generate a computational airway tree model. A full
description of the model was previously provided (69). To summarize,
the airway tree was derived from a thoracic X-ray computed tomography image including up to the eighth-generation airways and the
remaining generations were constructed using a volume filling algorithm that preserved the anatomical branching geometry (69).
Airways located within two voxels (6.25 mm) of an MRI ventilation defect or distal to a ventilation defect were labeled as related to
the defect. These airways were identified using custom software
designed in MATLAB and narrowed to 10% of their initial diameter,
effectively increasing their resistance by a factor of 104 according to
Poiseuille’s law (52). Airways larger than the 14th generation in the
airway tree were excluded to ensure that we evaluated only small
airways ⬍2 mm in diameter. We evaluated the impact of small airway
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constriction, which has been shown to play a critical role in increased
airway impedance and ventilation defects (16). Figure 1 shows a
schematic outlining MR image processing steps and the integration of
MRI data into the computational model to generate patient-specific
predictions. Airway impedance predictions were generated as previously described from these individually modified airway trees (12,
52). First, the airway lengths and diameters were reduced to 80% of
their original total lung capacity volume. The flow in the nonterminal
airways was described using Womersley flow (43) using the following
equation:
Z a共 f 兲 ⫽

i2fairla
r2a

冋

1⫺

2J1共␣a兹⫺i兲
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where i is the unit imaginary number, f is the oscillation frequency in
Hz, air is the density of air (1.16 kg/m3), la is the length and ra is the
radius of the airway, J0 and J1 are the complex Bessel functions of
order 0 and 1, respectively, and ␣a is the Womersley number for the
airway given by
␣a ⫽ ra

冑

2air f
air

(2)

where air is the dynamic viscosity of humid air at 37°C (1.85 ⫻ 10⫺5
Pa/s).
To model the compliance of the lung parenchyma, each terminal
airway was modeled as an alveolar compartment with a known
elastance. Then, the impedance of a terminal airway is given by

Zt ⫽ Za ⫺ i

Et


(3)

where E is the elastance of the terminal airway unit, set to 53
cmH2O/l as was done previously (52). The resistance of the upper
airways and the chest wall were each assigned a value of 0.5
cmH2O·s/l (6, 7, 59), and the elastance of the chest wall was
assigned a value of 10.6 cmH2O/l (5). Finally, the effects of upper
airway shunt were included using previously published values
(18). These values were added to the lung resistance and reactance
to calculate the final values for respiratory system resistance and
reactance.
Statistics. The Shapiro-Wilk test was used to test data normality,
and nonparametric tests were used when the data were not normally
distributed. Independent sample t-tests and Mann-Whitney U-tests
were used to evaluate differences between patients with asthma and
COPD patients. Levene’s test for equality of variances was used to
test if the variance in the data was equal between two groups, and
when the variance was not equal, Welch’s correction was applied to
two-tailed independent sample t-tests. The Holm-Bonferroni correction was used to adjust for multiple comparisons. Univariate relationships were evaluated using Spearman correlations () because the data
were not normally distributed. Significant relationships identified
using Spearman correlations were evaluated using linear regression.
Results were considered statistically significant when the probability
of making a Type I error was less than 5% (P ⬍ 0.05). All statistical
tests were performed using SPSS 24.0 (IBM).

Fig. 1. Pipeline for coregistration of MRI ventilation defects with computational airway tree model. A: hyperpolarized 3He MRI shown in cyan coregistered with
anatomical 1H MRI in greyscale. B: thoracic cavity, including the lungs, was automatically segmented using a manually seeded algorithm and ventilation defects
identified, shown in black. C: an asymmetric branching computational airway tree model used to calculate respiratory system impedance. D: ventilation defect
map was coregistered to the airway tree model. Small airways that were within or distal to a ventilation defect were identified and narrowed to 10% of their
original diameter. Ventilation defects are in gray and the airways related to defects are in yellow.
J Appl Physiol • doi:10.1152/japplphysiol.01031.2017 • www.jappl.org
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RESULTS

Participant demographics. As shown in Table 1, 100 participants were evaluated, including 50 subjects with asthma (17
mild-moderate and 33 severe) and 50 ex-smokers. Within the
ex-smoker group, 28 subjects had COPD [12 mild (GOLD I),
11 moderate (GOLD II), and 5 severe (GOLD III)]. The
ex-smokers were significantly older than the subjects with
asthma (P ⬍ 0.001). Forced expiratory volume in 1 s (FEV1)
was significantly higher in the ex-smokers as compared with
the subjects with asthma (P ⬍ 0.001) and the subjects with
COPD (P ⬍ 0.001), and plethysmography-measured airways
resistance was significantly greater in the asthma group as
compared with the COPD group (P ⬍ 0.001) and the exsmokers (P ⬍ 0.001). As shown in Fig. 2, subjects with COPD
had significantly greater VDP than ex-smokers (P ⬍ 0.001)
and subjects with asthma (P ⬍ 0.001), but there was not a
significant difference in VDP between subjects with asthma
and ex-smokers (P ⫽ 0.4). FOT-measured reactance (5 Hz)
was significantly more negative in patients with asthma as
compared with COPD subjects (P ⫽ 0.04) and ex-smokers
(P ⫽ 0.02). FOT-measured resistance at 5 Hz and 5–19 Hz,
related to the obstruction of all airways and in the lung
periphery respectively, was significantly greater in patients
with asthma as compared with COPD (resistance 5 Hz: P ⬍
0.001; resistance 5–19 Hz: P ⬍ 0.001) and ex-smokers (resistance 5 Hz: P ⬍ 0.001; resistance 5–19 Hz: P ⬍ 0.001). There
was no significant difference in FOT-measured resistance (5
Hz: P ⫽ 1.0; 5–19 Hz: P ⫽ 0.8) or reactance (P ⫽ 1.0)
between ex-smokers and COPD patients.
Pulmonary function test, forced oscillation technique, and
3
He MRI VDP relationships. In the asthma and COPD patient
groups, VDP was significantly related to measures of airway
obstruction from the pulmonary function tests. In subjects with
asthma, VDP was significantly related to FEV1 ( ⫽ ⫺0.7,
P ⬍ 0.001), forced vital capacity (FVC) ( ⫽ ⫺0.4, P ⫽
0.003), and FEV1/FVC ( ⫽ ⫺0.7, P ⬍ 0.001). In the patients
with COPD, VDP was also significantly related to FEV1
( ⫽ ⫺0.5, P ⫽ 0.004) and FEV1/FVC ( ⫽ ⫺0.6, P ⫽
0.002), and the relationship between VDP and FVC was
borderline significant ( ⫽ ⫺0.4, P ⫽ 0.051). In the nonCOPD ex-smoker group, VDP was not significantly related to
FEV1 ( ⫽ 0.2, P ⫽ 0.5), FVC ( ⫽ 0.2, P ⫽ 0.5), or FEV1/
FVC ( ⫽ ⫺0.1, P ⫽ 0.7).

Plethysmography-measured airways resistance and FOTmeasured respiratory system resistance have previously been
studied together and shown to have a moderately strong correlation (36). We repeated this analysis in our patients and
found moderately strong correlations between plethysmography-measured airways resistance and FOT resistance at 5 Hz,
as expected (asthma:  ⫽ 0.7, P ⬍ 0.001; ex-smokers:  ⫽ 0.7,
P ⬍ 0.001; COPD:  ⫽ 0.6, P ⫽ 0.001).
As shown in Fig. 3, MRI VDP was moderately but significantly correlated with FOT-measured respiratory system resistance (5 Hz:  ⫽ 0.3, P ⫽ 0.02) and reactance (5 Hz:  ⫽ ⫺0.5,
P ⬍ 0.001) in subjects with asthma, whereas these measurements
were not correlated in COPD patients (resistance 5 Hz:
 ⫽ ⫺0.04, P ⫽ 0.8; reactance 5 Hz:  ⫽ ⫺0.2, P ⫽ 0.4) or
ex-smokers (resistance 5 Hz:  ⫽ ⫺0.3, P ⫽ 0.2; reactance 5
Hz:  ⫽ 0.3, P ⫽ 0.2). In both subjects with asthma ( ⫽ 0.5,
P ⬍ 0.001) and patients with COPD ( ⫽ 0.5, P ⫽ 0.01),
resistance reflecting peripheral abnormalities (5–19 Hz) was
significantly correlated with VDP, but these measurements
were not correlated in ex-smokers ( ⫽ ⫺0.2, P ⫽ 0.4).
Relationships with disease control and quality of life scores.
All participants with asthma were stratified using the ACQ
(well controlled ⫽ ACQ ⱕ 2, poorly controlled ⫽ ACQ ⬎ 2)
as previously described (68). Ex-smokers (including subjects
with and without COPD) were classified based on the presence
of an exacerbation requiring hospitalization within 2.5 yr, such
that patients who had been hospitalized at least once because of
COPD or pneumonia (and would clinically be considered
exacerbators) were classified as poorly controlled. Nine out of
fifty ex-smokers experienced exacerbations, including seven
patients with COPD and two subjects from the non-COPD
group. As shown in Fig. 4, FEV1 was significantly lower in
patients with poorly controlled asthma (P ⫽ 0.04) but not
ex-smokers with exacerbations (P ⫽ 0.08). Plethysmographymeasured airways resistance was significantly greater in patients with poorly controlled asthma (P ⫽ 0.03) and exsmokers with exacerbations (P ⫽ 0.04), whereas VDP was
significantly greater in patients with poorly controlled asthma
(P ⫽ 0.03) but not in ex-smokers with exacerbations (P ⫽ 0.1).
In subjects with poorly controlled asthma, FOT-measured
respiratory system reactance (5 Hz: P ⫽ 0.03), resistance of all
airways (5 Hz: P ⫽ 0.01), and the resistance-reflecting peripheral airways (5–19 Hz: P ⫽ 0.006) were significantly different

Table 1. Subject demographics
Male, n
Age, yr
BMI, kg/m2
Height, cm
FEV1, %pred
FVC, %pred
FEV1/FVC, %
TLC, %pred
RV/TLC, %
DLCO, %pred
Raw, %pred

All (n ⫽ 100)

Asthma (n ⫽ 50)

COPD (n ⫽ 28)

Ex-Smokers (n ⫽ 22)

54
61 ⫾ 16
28 ⫾ 4
168 ⫾ 8
78 ⫾ 26
89 ⫾ 20
65 ⫾ 15
102 ⫾ 15
43 ⫾ 9

21
49 ⫾ 12
28 ⫾ 4
168 ⫾ 8
70 ⫾ 23
83 ⫾ 20
64 ⫾ 15
103 ⫾ 15
41 ⫾ 9

127 ⫾ 80

171 ⫾ 83

19
75 ⫾ 8
26 ⫾ 4
170 ⫾ 8
74 ⫾ 25
94 ⫾ 19
56 ⫾ 10
107 ⫾ 16
47 ⫾ 9
60 ⫾ 21
95 ⫾ 43

14
70 ⫾ 10
30 ⫾ 4
168 ⫾ 8
102 ⫾ 20
95 ⫾ 20
80 ⫾ 15
95 ⫾ 13
40 ⫾ 8
83 ⫾ 15
65 ⫾ 25

Asthma-COPD (P)

Asthma-Ex-Smokers (P)

COPD-Ex-smokers (P)

⬎0.001
0.5
1.0
1.0
0.06
0.02
0.8
0.04

⬍0.001
0.03
1.0
⬍0.001
0.1
⬍0.001
0.1
1.0

⬍0.001

⬍0.001

0.2
0.003
1.0
⬍0.001
1.0
⬍0.001
0.02
0.04
⬍0.001
0.6

Values are means ⫾ SD; n ⫽ no. of subjects. Significance of difference between groups determined with a one-way ANOVA with Bonferroni post hoc test.
%pred, percentage of predicted value; BMI, body mass index; COPD, chronic obstructive pulmonary disorder; DLCO, diffusing capacity of the lung for carbon
monoxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC, total lung capacity; RV, residual volume; Raw, airways resistance.
J Appl Physiol • doi:10.1152/japplphysiol.01031.2017 • www.jappl.org
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Fig. 2. VDP and FOT-measured resistance and reactance in asthmatic, COPD, and ex-smoker subgroups. A: VDP for asthma (n ⫽ 50) and COPD (n ⫽ 28,
P ⬍ 0.001), and COPD and ex-smoker subgroups (n ⫽ 22, P ⬍ 0.001) were significantly different, but VDP was not different between asthmatic and ex-smoker
groups (P ⫽ 0.4). B: FOT-measured reactance at 5 Hz was significantly greater in the asthmatic as compared with the COPD subgroup (P ⫽ 0.04) and the
ex-smoker group (P ⫽ 0.02). Respiratory system reactance was not different between COPD and ex-smoker subgroups (P ⫽ 1.0). C: FOT-measured resistance
at 5 Hz was significantly greater in the asthmatic as compared with the COPD (P ⬍ 0.001) and ex-smoker (P ⬍ 0.001) subgroups, but it was not different between
COPD and ex-smoker subgroups (P ⫽ 1.0). D: FOT-measured resistance at 5–19 Hz was significantly greater in the asthmatic as compared with the COPD
(P ⬍ 0.001) and ex-smoker (P ⬍ 0.001) subgroups but was not different between COPD and ex-smokers (P ⫽ 0.8). The two non-COPD ex-smokers who
experienced exacerbations are indicated by asterisk symbol (*). ES4: FEV1 ⫽ 102%pred, FVC ⫽ 97%pred, FEV1/FVC ⫽ 80%, resistance at 5 Hz ⫽ 4.0
cmH2O·s/l, reactance at 5 Hz ⫽ ⫺1.7cmH2O·s/l, resistance at 5–19 Hz ⫽ 0.0 cmH2O·s/l, VDP ⫽ 2%. ES14: FEV1 ⫽ 81%pred, FVC ⫽ 70%pred, FEV1/
FVC ⫽ 88%, resistance at 5 Hz ⫽ 4.0cmH2O·s/l, reactance at 5 Hz ⫽ ⫺2.4 cmH2O·s/l, resistance at 5–19 Hz ⫽ 0.3 cmH2O·s/l, VDP ⫽ 1%. %pred, percentage
of predicted value; COPD, chronic obstructive pulmonary disease; ES, ex-smoker; FEV1, forced expiratory volume in 1 s; FOT, force oscillation technique; FVC,
forced vital capacity; VDP, ventilation defect percentage.

than in patients with well-controlled asthma. None of the FOT
measures of airway impedance (reactance 5 Hz: P ⫽ 0.2;
resistance 5 Hz: P ⫽ 0.6; resistance 5–19 Hz: P ⫽ 0.3) were
significantly different in ex-smokers with exacerbations.
In patients with asthma, as shown in Fig. 5, the AQLQ score
was weakly correlated only with FOT-measured peripheral
resistance (5–19 Hz:  ⫽ ⫺0.3, P ⫽ 0.04) and VDP
( ⫽ ⫺0.3, P ⫽ 0.04), and not with any other measurement
acquired. It should be noted that when evaluating quality of life
using the AQLQ, a higher score indicates a better patientperceived quality of life, but when using the SGRQ, a higher
score indicates worse patient-perceived quality of life. Quality
of life in patients with COPD measured using the SGRQ score
was significantly correlated with FEV1 ( ⫽ ⫺0.5, P ⫽ 0.006),
plethysmography-measured airways resistance ( ⫽ 0.4, P ⫽
0.03), FOT-measured resistance of the lung periphery, (5–19
Hz:  ⫽ 0.4, P ⫽ 0.04), and VDP ( ⫽ 0.6, P ⫽ 0.003). SGRQ
scores were not significantly related to FOT-measured resistance (5 Hz:  ⫽ 0.1, P ⫽ 0.5) or reactance (5 Hz:  ⫽ ⫺0.2,

P ⫽ 0.3). In the non-COPD ex-smoker group, SGRQ scores
were only significantly related to plethysmography-measured
airways resistance ( ⫽ 0.5, P ⫽ 0.01).
Experimental and model impedance measurements. As
shown in Fig. 6, FOT-measured resistance of all airways (5
Hzmeas) was not significantly related to model-predicted
resistance (5 Hzpred) in subjects with asthma ( ⫽ 0.2, P ⫽
0.2) or in ex-smokers ( ⫽ ⫺0.3, P ⫽ 0.2) and COPD
patients ( ⫽ 0.001, P ⫽ 1.0). However, FOT-measured
respiratory system reactance (5 Hzmeas) was significantly
related to model-predicted reactance (5 Hzpred) in subjects
with asthma (slope ⫽ 1.4 ⫾ 0.6,  ⫽ 0.5, P ⫽ 0.001) but
not in COPD patients ( ⫽ 0.2, P ⫽ 0.4) or ex-smokers ( ⫽
⫺0.3, P ⫽ 0.2). In contrast, FOT-measured peripheral
resistance (5–19 Hzmeas) was significantly correlated with
model-predictions (5–19 Hzpred) in COPD patients
(slope ⫽ 2.6 ⫾ 0.7,  ⫽ 0.5, P ⫽ 0.004) but not in exsmokers ( ⫽ ⫺0.1, P ⫽ 0.6) or subjects with asthma
( ⫽ 0.2, P ⫽ 0.1).
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Fig. 3. Relationships for VDP and FOT measurements. Top: FOT-measured resistance at 5 Hz was weakly but significantly correlated with VDP in subjects with
asthma (n ⫽ 50; slope ⫽ 0.05 ⫾ 0.03,  ⫽ 0.3, P ⫽ 0.02) but not in COPD patients (n ⫽ 28;  ⫽ ⫺0.04, P ⫽ 0.8) or ex-smokers (n ⫽ 22;  ⫽ ⫺0.3, P ⫽ 0.2).
FOT-measured reactance at 5 Hz was significantly correlated with VDP in patients with asthma (slope ⫽ ⫺0.12 ⫾ 0.04,  ⫽ ⫺0.5, P ⬍ 0.001) but not in COPD
patients ( ⫽ ⫺0.2, P ⫽ 0.4) or ex-smokers ( ⫽ 0.3, P ⫽ 0.2). FOT-measured resistance at 5–19 Hz was significantly correlated with VDP in both patients with
asthma (slope ⫽ 0.07 ⫾ 0.02,  ⫽ 0.5, P ⬍ 0.001) and COPD patients (slope ⫽ 0.02 ⫾ 0.007,  ⫽ 0.5, P ⫽ 0.01) but not in ex-smokers ( ⫽ ⫺0.2, P ⫽ 0.4).
Middle: three representative subjects with asthma with worsening VDP and FOT-measured impedance from left to right. Bottom: three representative COPD
subjects with worsening VDP and FOT-measured impedance from left to right. COPD, chronic obstructive pulmonary disease; FOT, force oscillation technique;
VDP, ventilation defect percentage.
DISCUSSION
3

In ex-smokers and patients with asthma, He MRI ventilation heterogeneity and oscillometry measurements were evaluated as was their relationship with one another, with quality of
life scores and with disease control/exacerbations. We also
generated respiratory impedance predictions using an airway

tree model that was modified based on patient-specific MRI
ventilation maps and evaluated model-based and experimental
impedance measurements. We made a number of important
observations, including the following: 1) in subjects with
asthma, MRI VDP was related to FOT-measured reactance at
5 Hz, resistance at 5 Hz, and resistance at 5–19 Hz, but in
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Fig. 4. Differences in FEV1, VDP, and FOT
impedance stratified by disease control. Subjects were stratified based on disease control
using the Asthma Control Questionnaire
(ACQ) for patients with asthma (n ⫽ 50) or
the presence of at least a single exacerbation
requiring hospitalization in ex-smokers [including those with and without COPD (n ⫽
50)]. A: FEV1 was significantly different in
patients with asthma with poor control (P ⫽
0.04) but not in ex-smokers with exacerbations (P ⫽ 0.08). B: plethysmography-measured airways resistance was significantly
decreased in patients with poorly controlled
asthma (P ⫽ 0.03) and COPD exacerbators
(P ⫽ 0.04). C: VDP was significantly increased in patients with poorly controlled
asthma (P ⫽ 0.03) but not in ex-smokers
experiencing an exacerbation (P ⫽ 0.1). D:
FOT-measured reactance at 5 Hz was significantly different in patients with poorly controlled asthma (P ⫽ 0.03) but not in exsmokers experiencing an exacerbation (P ⫽
0.2). E: FOT-measured resistance at 5 Hz
was significantly increased in patients with
poorly controlled asthma (P ⫽ 0.01) but not
in COPD exacerbators (P ⫽ 0.6). F: FOTmeasured resistance at 5–19 Hz was significantly different in patients with poorly controlled asthma (P ⫽ 0.006) but not in patients with COPD exacerbations (P ⫽ 0.3).
The two non-COPD ex-smokers who experienced exacerbations are indicated by asterisk symbol (*). COPD, chronic obstructive
pulmonary disease; FEV1, forced expiratory
volume in 1 s; FOT, force oscillation technique; FVC, forced vital capacity; VDP,
ventilation defect percentage.

COPD patients, only VDP and resistance at 5–19 Hz were
related, and in ex-smokers, MRI VDP was not related to
FOT-measured impedance; 2) VDP and FOT-measured reactance and resistance were independently correlated with AQLQ
(in patients with asthma) and SGRQ (in COPD patients) but
were not correlated with SGRQ in ex-smokers without COPD;
3) FOT-measured impedance and MRI VDP were independently related to disease control in patients with asthma but not
in ex-smokers or COPD patients; and finally 4) in patients with
asthma, measured and predicted respiratory impedance (5 Hz)
were significantly correlated, whereas in patients with COPD,
only measured and predicted resistance reflecting the lung
periphery (5–19 Hz) were related.

First, we observed that FOT-measured resistance and reactance were correlated with MRI VDP, providing direct evidence that the biomechanical properties of the respiratory
system are related to ventilation heterogeneity as defined by
VDP in both patients with asthma and COPD patients. In
particular, in subjects with asthma, resistance at 5 Hz, reactance at 5 Hz, and resistance at 5–19 Hz were weakly to
moderately related to VDP, but in COPD, only resistance at
5–19 Hz was moderately related. This suggests that there may
be differences in the etiology of ventilation defects in patients
with asthma and patients with COPD, and that in the COPD
patients studied here, VDP was dominated by resistance reflecting the lung periphery. In subjects with asthma, the rela-
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Fig. 5. Relationships between FOT-measured
resistance and MRI VDP with quality of life.
Quality of life was measured using the Asthma
Quality of Life Questionnaire (AQLQ) in patients with asthma (n ⫽ 50) and the St.
George’s Respiratory Questionnaire (SGRQ)
in ex-smokers (n ⫽ 22) and COPD patients
(n ⫽ 28). In patients with asthma, AQLQ
relationships with FOT-measured resistance at
5 Hz ( ⫽ ⫺0.2, P ⫽ 0.2) (A), FOT-measured
resistance at 5–19 Hz (slope ⫽ ⫺0.4 ⫾ 0.2,
 ⫽ ⫺0.3, P ⫽ 0.04) (B), and MRI-measured
VDP (slope ⫽ ⫺2.2 ⫾ 0.9,  ⫽ ⫺0.3, P ⫽
0.04) (C). In COPD patients and ex-smokers,
SGRQ relationships with FOT-measured resistance at 5 Hz (COPD:  ⫽ 0.1, P ⫽ 0.5; ES:
 ⫽ 0.4, P ⫽ 0.07) (D), FOT-measured resistance at 5–19 Hz (COPD: slope ⫽ 0.01 ⫾
0.006,  ⫽ 0.4, P ⫽ 0.04; ES:  ⫽ 0.2, P ⫽
0.3) (E), and MRI-measured VDP (COPD:
slope ⫽ 0.3 ⫾ 0.1,  ⫽ 0.6, P ⫽ 0.003; ES:
 ⫽ ⫺0.3, P ⫽ 0.2) (F). COPD, chronic
obstructive pulmonary disease; ES, ex-smoker; FOT, force oscillation technique; VDP,
ventilation defect percentage.

tionships between respiratory system resistance and reactance
with VDP are not strong and there is a great deal of variability
in the relationships, especially at low VDP. Certainly, these
correlations were quite weak, and to some extent, a small group
of patients (subjects with asthma with elevated VDP and
respiratory impedance) helped to drive these associations. This
also highlights the fact that only some of the ventilation
abnormalities caused by increased resistance are captured by
VDP. Future work with higher spatial resolution images will
include an investigation of higher order MRI ventilation heterogeneity biomarkers (like texture features) to determine if

these higher order features explain some of this variance. On
the other hand, oscillometry did not fully explain ventilation
defects observed in MRI, although elevated resistance and
ventilation defects are both known to be mechanistically due to
airway narrowing in asthma. Finally, the fact that elevated
Resistance [R (5-19Hz)] and VDP may contribute to reduced
quality of life in patients with asthma and COPD patients is
important, but it is also clear that there are additional factors
involved that were not accounted for here.
In patients with asthma, there was some contribution to total
resistance and reactance, as well as resistance reflecting the
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Fig. 6. Relationships for model-predicted and FOT-measured respiratory system impedance. A: FOT-measured resistance at 5 Hzmeas was not significantly related
to model-predicted resistance at 5 Hzpred in patients with asthma (n ⫽ 50,  ⫽ 0.2, P ⫽ 0.2), COPD patients (n ⫽ 28,  ⫽ 0.001, P ⫽ 1.0), or ex-smokers
(n ⫽ 22,  ⫽ ⫺0.3, P ⫽ 0.2). B: FOT-measured reactance at 5 Hzmeas was significantly related to model-predicted reactance at 5 Hzpred in patients with asthma
(slope ⫽ 1.4 ⫾ 0.6,  ⫽ 0.5, P ⫽ 0.001) but not in COPD patients ( ⫽ 0.2, P ⫽ 0.4) or ex-smokers ( ⫽ ⫺0.3, P ⫽ 0.2). C: FOT-measured resistance at 5–19
Hzmeas was significantly correlated with model-predicted resistance at 5–19 Hzpred in COPD (slope ⫽ 2.6 ⫾ 0.7,  ⫽ 0.5, P ⫽ 0.004) but not in patients with
asthma ( ⫽ 0.2, P ⫽ 0.1) or ex-smokers ( ⫽ ⫺0.1, P ⫽ 0.6). COPD, chronic obstructive pulmonary disease; FOT, force oscillation technique; VDP, ventilation
defect percentage.

lung periphery, supporting the idea that asthma involves all
airways. In addition, it is clear from the plots shown in Fig. 3
that for some patients with asthma, respiratory impedance is
severely elevated while VDP remains low, weakening the
relationship between impedance and VDP. This suggests that
there is a mechanism causing elevated respiratory impedance
that is not reflected in VDP. Future investigations may reveal
the mechanism behind this phenomenon and how this may be
captured using hyperpolarized noble gas MRI. Interestingly,
non-COPD ex-smokers had similar small airway resistance to
the subjects with COPD but had significantly lower VDP. This
suggests that similar biomechanical changes are present in the
lung periphery in ex-smokers, but they are not severe enough
to cause ventilation defects. These findings certainly support
the ongoing conversation about the important role of small
airways disease in COPD patients (37) and provide new impetus for the development of small airways treatments of
COPD. Previously described computational modeling (16) and
ventilation heterogeneity studies (27, 53) have focused on
asthma, but to our knowledge, our observations in COPD
patients are novel. A recent SPECT study (31) evaluated the
impact of bronchoconstriction in patients with asthma and
suggested that respiratory impedance may be too complex to be
directly evaluated using ventilation imaging. However, here we
showed that MRI ventilation abnormalities may be explained
in part by oscillometry measurements, and surprisingly, MRI
ventilation abnormalities measured during a static breath-hold
are significantly related to impedance measurements made
during tidal breathing.
Second, we observed that FOT-measured peripheral lung
resistance and VDP were weakly but significantly related to
quality of life scores in patients with asthma and COPD, but
not in ex-smokers. This is important because for FEV1, which
is the most commonly used measurement of obstructive lung
disease, relationships with important outcomes like quality of
life are generally weak to insignificant (1, 70, 85). As patientcentered care becomes a priority in clinical settings, patient
quality of life is becoming an extremely important clinical
outcome. Therefore, for research purposes and for treatment

decisions, identifying meaningful relationships between physiological measurements and these outcomes is increasingly
important. There is now strong motivation to develop and
identify quantitative tools that are related to outcomes such as
quality of life so that they may be predicted in individual
patients. With this in mind, the primary objective of our study
was to evaluate the relationships between ventilation MRI and
FOT with patient quality of life and disease control/exacerbations. Although the metrics we studied do not fully explain the
variation in quality of life outcomes, the relationships shown
here suggest that FOT and MRI do provide clinically useful
measurements for this purpose in patients with asthma and
COPD patients.
Perhaps more importantly for clinical decision makers, we
observed that plethysmography-measured airways resistance
was significantly worse in subjects with asthma, ex-smokers,
and COPD patients with poorly controlled disease, whereas
FOT-measured resistance and reactance as well as VDP were
all significantly worse in patients with poorly controlled
asthma. Although we did not observe significant relationships
in COPD patients or ex-smokers, this result may stem from the
small number of exacerbations in these patients, which was
used as a surrogate end point for disease control. It is understood that plethysmography-measured airways resistance and
FOT respiratory system resistance are significantly correlated,
although these correlations are not always strong (36). A power
analysis assuming unequal sample size using hospitalizations
as a conservative measure of disease control revealed that 104
ex-smokers (including COPD patients) would be required for
resistance at 5–19 Hz as a predictor of hospitalizations,
whereas only 40 patients would be needed for airways resistance. Larger studies to investigate the power of both FOT and
MRI to predict and prevent COPD hospitalization will be
important because COPD exacerbations constitute a large
health utilization burden in Canada (33, 78) and around the
world (32, 61).
Finally, we generated impedance predictions using an airway tree model adapted using ventilation MRI measurements.
It is important to note here that we did not include all possible
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mechanisms that lead to increased ventilation heterogeneity or
pulmonary impedance in these calculations. Rather, our goal
was to investigate the role that peripheral airway narrowing
may play in ventilation defects observed in obstructive lung
disease, independent of other factors such as heterogeneous
increased elastance in emphysema. This was done to test our
hypothesis that heterogeneous peripheral airway narrowing
plays an important role in ventilation heterogeneity, and subsequently in patient quality of life. We were not surprised to
find that the experimental and model-predicted values of
resistance at 5 Hz were not significantly correlated, because
it is likely that some airway narrowing may not directly lead
to ventilation defects in patients. We also observed that
FOT-measured and model-predicted reactances were significantly related in subjects with asthma, which was in agreement with previous findings (12, 54, 77). Finally, the measured and predicted resistance reflecting the lung periphery
(5–19 Hz) was significantly correlated in COPD patients,
but not subjects with asthma, which is consistent with our
understanding that small airways disease plays a dominant
role in COPD (37), whereas in asthma, both large and small
airways are involved (35).
It is important to note that although there were moderately
strong correlations between the measured and predicted impedance values, the predicted values were significantly smaller
(based on the slopes of the linear regression). This was expected because previous work (12) showed that up to 75% of
the small airways need to be constricted to achieve model and
experimental measurement agreement. Impedance predictions
were systematically underestimated (12) when only airways
within a defect were considered, supporting previous demonstrations (71) that showed constriction of airways beyond those
proximal to ventilation defects is required to simulate impedance measurements in patients with asthma.
We acknowledge and recognize a number of study limitations, including the fact that we considered ventilation defects
only and not regions of decreased or partial ventilation. Based
on previous modeling studies (71) and MRI evidence of patchy
ventilation sometimes observed in subjects with asthma and
ex-smokers, it would be relevant to consider hyperintense
ventilation regions as well as hypointense regions that are not
captured by VDP. We note as well that the airway tree (69)
used in the modeling studies was not patient-specific, nor were
the impedance values of the upper airway and chest wall.
However, we expect these factors to contribute much less to
respiratory impedance than the changes occurring within the
lung itself in obstructive lung disease. An additional limitation
to this work is the fact that only airway caliber was modified in
our modeling calculations, not elastance. In both asthma and
COPD patients, a uniform elastance was assumed for all
terminal airways, which is not always true in COPD. This
simple model was used to highlight the impact of small airway
abnormalities. Despite these limitations, which likely contributed to the substantial variability observed in the relationships,
we observed some significant correlations between measured
and model-predicted impedance reflecting the lung periphery
in this simplified model. This suggests that our model identifies
a significant driving factor in the relationship between ventilation heterogeneity and respiratory impedance, which is important for further model development. Future work will include the addition of variable elastic or viscoelastic parameters

to simulate changes to parenchymal tissue and an investigation
of how the size and spatial distribution of defects are related to
changes in respiratory impedance. We are now refining the
image registration and airway tree so that we can study this in
more detail with data acquired with higher spatial resolution in
3-D. For example, we are developing image-processing tools to
answer the questions related to central versus peripheral defects and their relationship with resistance. We also think that
these approaches may help explain constriction or obstruction
proximal to a defect after a methacholine challenge and after
treatment with a bronchodilator. All of these analyses are
ongoing with new 129Xe MRI data sets that are now being
acquired in 3-D with improved isotropic spatial resolution.
Another limitation of this work is the use of hospitalizations
as a surrogate measure of disease control in ex-smokers.
Although hospitalizations have the highest impact on patients
and the health care system (78), only 9 of 50 ex-smokers
studied here experienced an exacerbation, which certainly
diminished statistical power; larger studies will be needed to
explore these relationships. An additional limitation of this
work is the relatively mild disease severity of the COPD
population. Although our patient population did include severe
COPD subjects , most subjects had mild to moderate disease,
and none had very severe (GOLD IV) disease. Further studies
including more subjects with severe disease may be required to
verify the applicability of our findings to severe disease. The
FOT-derived results were certainly limited by our use of raw
values, which were not corrected for age or anthropomorphic
factors. This means that the respiratory impedance differences
observed may be due, in part, to differences in age and body
mass index, and this is a limitation of our approach. Although
we showed that patient height was not different between
groups, patient size should be considered when evaluating FOT
values. Finally, although we observed significant relationships
between FOT measurements of resistance and reactance with
MRI VDP and patient quality of life, these relationships were
of moderate to weak strength, which means other factors, not
determined here, play a role.
In conclusion, we made oscillometry and MRI measurements in ex-smokers and patients with asthma and directly
compared these measurements with disease control/exacerbations and patient quality of life scores. We observed significant
relationships for FOT-measured impedance and VDP with
quality of life, providing evidence that airway resistance and
reactance are reflective of MRI ventilation defects, and importantly, they are both related to patient quality of life. We also
used MRI ventilation defects to generate patient-specific computational airway model predictions of respiratory system impedance and, for the first time, compared these predictions with
experimental measurements. Taken together, these results provide strong motivation for multiscale studies that explore how
small airways disease and ventilation abnormalities may explain and help improve disease control and quality of life in
patients.
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